Vertex Pharmaceuticals Inc
VRTX· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2013 | Q1 2012 | Q1 2011 | Q1 2010 |
|---|---|---|---|---|
| Revenue | $328.37M | $438.74M | $73.66M | $22.43M |
| Net Income | -$308.02M | $91.59M | -$176.10M | -$165.27M |
| EPS Diluted | -$1.43 |
Vertex Pharmaceuticals Inc · CIK 875320 · Engraved from SEC EDGAR
| $0.43 |
| -$0.87 |
| -$0.83 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.